...company expects to meet with regulators and consider a path forward based on its findings.The TITAN...

...investors GV, Foresite Capital Management LLC, TPG Capital and First Round Capital. DNAnexus’ Apollo and Titan...

...soon follow, as both the Phase III ARCHES trial of Xtandi and the Phase III TITAN...
...Placebo + prednisone (n=602) NA 14.8 36.5 Johnson & Johnson (NYSE:JNJ) Erleada apalutamide Ph III TITAN...
...co-primary endpoints of overall survival (OS) and radiographic progression-free survival (rPFS) in the Phase III TITAN...

...an IDMC showed that Erleada apalutamide met the dual primary endpoints in the Phase III TITAN...
...approval of the second-generation androgen receptor antagonist in the indication are expected this year. On TITAN's...

...an IDMC showed that Erleada apalutamide met the dual primary endpoints in the Phase III TITAN...
...approval of the second-generation androgen receptor antagonist in the indication are expected this year. On TITAN's...

...marketed buprenorphine products -- once-monthly injectable Sublocade from Indivior plc (LSE:INDV) and implant Probuphine from Titan Pharmaceuticals Inc....
...lost $0.60 to $40.09 on Sept. 10, while Indivior was up 8.60p to 268.30p and Titan...
...Alkermes plc (NASDAQ:ALKS), Dublin, Ireland Braeburn Pharmaceuticals Inc., Princeton, N.J. Indivior plc (LSE:INDV), Richmond, Va. Titan Pharmaceuticals Inc....

...marketed buprenorphine products -- once-monthly injectable Sublocade from Indivior plc (LSE:INDV) and implant Probuphine from Titan Pharmaceuticals Inc....
...Alkermes lost $0.60 to $40.09 on Monday, while Indivior was up 8.60p to 268.30p and Titan...
...buprenorphine Sublocade (Brand), RBP-6000 (Compound #), buprenorphine (Generic) Vivitrol, naltrexone (Medisorb naltrexone, Vivitrex, XR-NTX) Alkermes plc Braeburn Pharmaceuticals Inc. Indivior plc Titan Pharmaceuticals Inc. ICER MATs medication-assisted...

...products -- the once-monthly injectable Sublocade from Indivior plc (LSE:INDV) and the implant Probuphine from Titan Pharmaceuticals Inc....
...England Comparative Effectiveness Public Advisory Council (CEPAC) on Nov. 8. Indivior plc (LSE:INDV), Richmond, Va. Titan Pharmaceuticals Inc....
...NASDAQ:TTNP), South San Francisco, Calif. Braeburn Pharmaceuticals Inc., Princeton, N.J. Business: Neurology Mary Romeo CAM2038 Probuphine Sublocade Suboxone Vivitrol Braeburn Pharmaceuticals Inc. Indivior plc Titan Pharmaceuticals Inc....

...products -- the once-monthly injectable Sublocade from Indivior plc (LSE:INDV) and the implant Probuphine from Titan Pharmaceuticals Inc....
...England Comparative Effectiveness Public Advisory Council (CEPAC) on November 8. Mary Romeo CAM2038 Methadone Probuphine Sublocade Suboxone sublingual film Vivitrol Braeburn Pharmaceuticals Inc. Indivior plc Titan Pharmaceuticals Inc....

...with a transmucosal buprenorphine-containing product. It also markets Suboxone sublingual film to treat opioid dependence. Titan Pharmaceuticals Inc....
...and to prevent relapse to opioid dependence following opioid detoxification. Indivior plc (LSE:INDV), Richmond, Va. Titan Pharmaceuticals Inc....
...Compound #), buprenorphine (Generic) Suboxone sublingual film, buprenorphine/naloxone Vivitrol, naltrexone (Medisorb naltrexone, Vivitrex, XR-NTX) Alkermes plc Braeburn Pharmaceuticals Inc. Indivior plc Titan Pharmaceuticals Inc. ICER Institute...